Company intelligence / Profile preview

Meritz

Frankfurt, Hesse, Germany

Ownership: Private
Employees: ~4000
Development stage: Other

Overview

Merz is a global, family-owned healthcare company based in Frankfurt, Germany, with a history spanning over 110 years. The company operates through three main business units: Merz Aesthetics, Merz Therapeutics, and Merz Consumer Care. Merz Aesthetics is a leading global provider of medical aesthetics, known for products like Xeomin and Radiesse. Merz Therapeutics focuses on addressing the unmet needs of patients suffering from movement disorders, neurological conditions, and other health issues. The company is particularly recognized for its expertise in botulinum neurotoxin therapy and its long-standing commitment to innovation in dermatology and neurology.

Therapeutic areas: NeurologyDermatology
Modalities: Small moleculeProteinBiologicBotulinum toxin
Industry: Biotech

Partnerships

LundbeckTeijin Pharma

Beyond the preview

Go deeper on Meritz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meritz.

Explore the full profile